Bio-Techne Corp. Files Q3 2025 10-Q
Ticker: TECH · Form: 10-Q · Filed: May 8, 2025 · CIK: 842023
| Field | Detail |
|---|---|
| Company | Bio-Techne Corp (TECH) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotechnology
TL;DR
Bio-Techne filed its Q3 2025 10-Q. Check financials.
AI Summary
Bio-Techne Corp. filed its 10-Q for the period ending March 31, 2025. The company, headquartered in Minneapolis, MN, operates in the biological products sector. This filing provides an update on its financial performance and business operations for the third quarter of its fiscal year.
Why It Matters
This filing provides investors and analysts with the latest financial data and operational insights for Bio-Techne Corp., crucial for understanding the company's performance and future prospects in the biotechnology sector.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing (10-Q) and does not inherently present new risks.
Key Players & Entities
- BIO-TECHNE Corp (company) — Filer of the 10-Q
- MINNEAPOLIS (location) — City of headquarters
- MN (location) — State of headquarters
- 20250331 (date) — End of reporting period
- 20250508 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The 10-Q filing is for the period ending March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 8, 2025.
What is the company's primary business sector?
The company's Standard Industrial Classification is Biological Products (No Diagnostic Substances) [2836].
Where is Bio-Techne Corp. headquartered?
Bio-Techne Corp. is headquartered in Minneapolis, MN.
What is the fiscal year end for Bio-Techne Corp.?
The fiscal year end for Bio-Techne Corp. is June 30.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding BIO-TECHNE Corp (TECH).